Your browser doesn't support javascript.
loading
Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study.
de Bruijn, Clara M A; Millot, Frédéric; Suttorp, Meinolf; Borisevich, Marina; Brons, Paul; Lausen, Birgitte; de Bont, Eveline S J M.
Afiliación
  • de Bruijn CMA; Departments of Paediatric Oncology/Haematology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Millot F; Departments of Paediatric Oncology/Haematology, Poitiers University Hospital, Poitiers, France.
  • Suttorp M; Paediatric Haemato-Oncology, Medical Faculty, Technical University, Dresden, Germany.
  • Borisevich M; Belarusian Research Centre for Paediatric Oncology, Haematology and Immunology, Minsk, Belarus.
  • Brons P; Departments of Paediatric Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Lausen B; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • de Bont ESJM; Departments of Paediatric Oncology/Haematology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Br J Haematol ; 185(4): 718-724, 2019 05.
Article en En | MEDLINE | ID: mdl-30843196
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido